Clinical Trial: A Study of Efgartigimod in Patients With IgG4-Related Disease

U.S., June 18 -- ClinicalTrials.gov registry received information related to the study (NCT07025330) titled 'A Study of Efgartigimod in Patients With IgG4-Related Disease' on June 09.

Brief Summary: The goal of this clinical trial is to learn if efgartigimod can treat IgG4-related disease in adults. The main questions it aims to answer are:

In patients with IgG4-related disease, does treatment with efgartigimod reduce the volume of the:

* lacrimal gland(s) and/or

* salivary gland(s) and/or

* pancreas

Participants will:

* Receive efgartigimod once weekly for up to 12 weeks

* Visit the clinic every one to six weeks for checkups and tests

* Be asked to complete questionnaires to see how they feel on efgartigimod

Study Start Date: Jul...